Benitec Biopharma updates FDA feedback on BB-301
- Received FDA feedback after Type C meeting in 3Q 2026
- FDA requested additional data including OPMD Natural History Study
- Pivotal study design to be confirmed in 1Q 2027
BNTC
Benitec Biopharma Inc. SEC filings
Every EDGAR filing for Benitec Biopharma Inc. (BNTC), newest first, with AI summaries and stories.
- Ticker
- BNTC
- CIK
- 1808898
- Sector
- Biotech and pharma
- Latest filing
- Oct 5
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINEEFFECTBenitec Biopharma Inc.BNTCLIVE ROUTINES-3Benitec Biopharma Inc.BNTCLIVE NOTABLE10-KBenitec Biopharma Inc.BNTCLIVE ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE4Benitec Biopharma Inc.BNTCLIVE J Kevin Buchi, insider filing for BNTC
J Kevin Buchi, reporting
ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE4Benitec Biopharma Inc.BNTCLIVE 2 insider filings
David Matthew Friedman, insider filing for BNTC
Show all 2
- 4Insider filing for BNTC
- 3New insider at BNTC
David Matthew Friedman, reporting
NOTABLE10-QBenitec Biopharma Inc.BNTCLIVE ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE10-K/ABenitec Biopharma Inc.BNTCLIVE ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE NOTABLE10-QBenitec Biopharma Inc.BNTCLIVE ROUTINEEFFECTBenitec Biopharma Inc.BNTCLIVE ROUTINES-3Benitec Biopharma Inc.BNTCLIVE ROUTINESCHEDULE 13G/ABenitec Biopharma Inc.BNTCLIVE Ownership stake disclosure by FRANKLIN RESOURCES INC (amended)
FRANKLIN RESOURCES INC, filed by
ROUTINE4Benitec Biopharma Inc.BNTCLIVE Sharon Mates, insider filing for BNTC
Sharon Mates, reporting
ROUTINE4Benitec Biopharma Inc.BNTCLIVE SUVRETTA CAPITAL MANAGEMENT, LLC, insider filing for BNTC
SUVRETTA CAPITAL MANAGEMENT, LLC, reporting · Aaron Cowen, reporting · +2 more
ROUTINE4Benitec Biopharma Inc.BNTCLIVE SUVRETTA CAPITAL MANAGEMENT, LLC, insider filing for BNTC
SUVRETTA CAPITAL MANAGEMENT, LLC, reporting · Aaron Cowen, reporting · +2 more
ROUTINESCHEDULE 13G/ABenitec Biopharma Inc.BNTCLIVE Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)
JANUS HENDERSON GROUP PLC, filed by
ROUTINESCHEDULE 13GBenitec Biopharma Inc.BNTCLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P., filed by
ROUTINE4Benitec Biopharma Inc.BNTCLIVE 5 insider filings
Sharon Mates, insider filing for BNTC
Show all 5
- 4Insider filing for BNTC
- 4Insider filing for BNTC
- 4Insider filing for BNTC
- 4Insider filing for BNTC
- 4Insider filing for BNTC
Sharon Mates, reporting
ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE4Benitec Biopharma Inc.BNTCLIVE 3 insider filings
Sophie Mukadam, insider filing for BNTC
Show all 3
- 4Insider filing for BNTC
- 4Insider filing for BNTC
- 4Insider filing for BNTC
Sophie Mukadam, reporting
ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE NOTABLE10-QBenitec Biopharma Inc.BNTCLIVE ROUTINEDEFA14ABenitec Biopharma Inc.BNTCLIVE NOTABLESCHEDULE 13D/ABenitec Biopharma Inc.BNTCLIVE Ownership stake disclosure by SUVRETTA CAPITAL MANAGEMENT, LLC (amended)
SUVRETTA CAPITAL MANAGEMENT, LLC, filed by
ROUTINE4Benitec Biopharma Inc.BNTCLIVE SUVRETTA CAPITAL MANAGEMENT, LLC, insider filing for BNTC
SUVRETTA CAPITAL MANAGEMENT, LLC, reporting · Aaron Cowen, reporting · +2 more
ROUTINE4Benitec Biopharma Inc.BNTCLIVE 2 insider filings
Sharon Mates, insider filing for BNTC
Show all 2
- 4Insider filing for BNTC
- 3New insider at BNTC
Sharon Mates, reporting
ROUTINE424B5Benitec Biopharma Inc.BNTCLIVE ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE ROUTINE424B5Benitec Biopharma Inc.BNTCLIVE ROUTINESCHEDULE 13G/ABenitec Biopharma Inc.BNTCLIVE Ownership stake disclosure by FRANKLIN RESOURCES INC (amended)
FRANKLIN RESOURCES INC, filed by
ROUTINE8-KBenitec Biopharma Inc.BNTCLIVE